A batch with four times the medicine’s normal dosage has been recalled, and Irish patients are urged to check their prescriptions.
10:58, 02 Jun 2026Updated 11:04, 02 Jun 2026
Prescription (stock image)(Image: Getty Images)
A medicine, which is prescribed in Ireland to treat hypertension, kidney disease and heart failure has been recalled after pills containing a much higher dosage than usual were found in two blister strips.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) issued a general recall notice on May 28 of Ramipril 2.5mg capsules after two blister strips containing 10mg capsules were found in a pack. The manufacturer of the drug, Crescent Pharma, said it was recalling the batch on the same day.
“Both batches were manufactured at the same site, and the issue appears to have occurred during the secondary packaging process for Batch GR155023,” the recall notice said.
Alison Cave, the chief safety officer of the MHRA, asked patients to check the packaging for batch number GR155023.
“If you have received this batch, check that the medication strength on the carton matches the blister strips inside,” Cave said.
“If the 2.5mg carton of Crescent Pharma Limited Ramipril contains blister strips that are labelled as Ramipril 10mg capsules, do not to take the medicine and contact your dispensing pharmacy.”
“If the carton contains blister strips that are correctly labelled as Crescent Pharma Limited Ramipril 2.5mg capsules, you do not need to take further action and should continue to take your medicine as usual.”
Anyone who thinks they may have taken the increased dose is advised to seek medical advice. Signs and symptoms include fatigue, lightheadedness, fainting or changes in kidney function.